US FDA 'working rapidly' on Pfizer Covid-19 vaccine decision
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Monday
August 08, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
MONDAY, AUGUST 08, 2022
US FDA 'working rapidly' on Pfizer Covid-19 vaccine decision

Coronavirus chronicle

Reuters
11 December, 2020, 11:20 pm
Last modified: 11 December, 2020, 11:24 pm

Related News

  • Iran says success of Vienna nuclear talks depends on Washington's flexibility
  • Taiwan is not a part of US but Chinese territory, says Chinese foreign minister
  • US drivers are using less gasoline. Let's keep it that way
  • US says it supports Israel's right to defend itself, urges no more escalation
  • China's July trade surplus with US widens slightly to $41.5b

US FDA 'working rapidly' on Pfizer Covid-19 vaccine decision

Pfizer has asked that the two-dose vaccine, developed with German partner BioNTech, be approved for use in people aged 16 to 85

Reuters
11 December, 2020, 11:20 pm
Last modified: 11 December, 2020, 11:24 pm
US FDA 'working rapidly' on Pfizer Covid-19 vaccine decision

The US Food and Drug Administration (FDA) said on Friday it was working rapidly to issue an emergency use authorization for Pfizer Inc's Covid-19 vaccine, setting the stage for the first Americans to be immunized as soon as Monday or Tuesday.

The FDA's decision making follows one of the last steps of its regulatory process: a panel of outside advisers on Thursday evening endorsed emergency use of the vaccine to help stem a pandemic that has killed more than 285,000 US residents.

US Department of Health and Human Services Secretary Alex Azar, which oversees the FDA, told ABC News that regulatory authorization should come within days and the federal government would work with the company to get the vaccine shipped out.

Pfizer has asked that the two-dose vaccine, developed with German partner BioNTech, be approved for use in people aged 16 to 85.

The companies last month said that a two-dose regimen of the vaccine was 95% effective in preventing illness from Covid-19, and detailed data released in the FDA's documents showed the vaccine began showing some protection even before volunteers received a second dose.

The vaccine is already approved in Britain, and people there began receiving the shots on Tuesday. Bahrain and Canada have also authorized the vaccine, and Canada expects to start inoculations next week.

The FDA has notified the US Centers for Disease Control and Prevention and Operation Warp Speed so that they can execute their plans for timely vaccine distribution, it said in a statement.

Healthcare workers, first responders and nursing home residents are expected to receive the first doses, but a wider rollout faces significant logistical challenges.

Another 2,902 US deaths were reported on Thursday, a day after a record 3,253 people died, a pace projected to continue for the next two to three months until the vaccine can be widely distributed.

For months, US President Donald Trump had pressured the FDA in tweets and press conferences to move more quickly, accusing staff and Pfizer of dragging their feet.

Shortly after the FDA's statement, the outgoing president criticized the agency for what he said was its slow handling of the vaccines and criticized FDA Commissioner Steven Hahn.

Trump said his "pushing" the agency had speed up new vaccine approval, but that the FDA was "still a big, old, slow turtle. Get the dam vaccines out NOW, Dr. Hahn @SteveFDA. Stop playing games and start saving lives!!!"

Pfizer shares rose 1% before the opening bell, while BioNTech US shares were flat.

World+Biz

US / FDA / Pfizer coronavirus vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • TBS file photo
    Now 99% Bangladesh products come under China’s duty-free offer
  • Photo: TBS
    Production loss feared as zone-wise industrial weekly closure mulled 
  • Representational image. File Photo: Minhaj Uddin/TBS
    LC settlement fell by $1.17b in July

MOST VIEWED

  • People line up for nucleic acid tests during lockdown, amid the coronavirus disease (COVID-19) pandemic, in Shanghai, China, May 26, 2022. REUTERS/Aly Song
    China's Sanya holiday hotspot shuts duty-free malls, venues to curb Covid
  • FILE PHOTO: People wearing protective face masks walk amid concerns over the new coronavirus disease (COVID-19) in Pyongyang, North Korea May 15, 2020, in this photo released by Kyodo. Mandatory credit Kyodo/via REUTERS
    North Korea marks end of first Covid wave, but risks persist
  • A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
    South Africa reports first death causally linked to Covid vaccine
  • 'Living with Covid': Where the pandemic could go next
    'Living with Covid': Where the pandemic could go next
  • A worker, wearing a protective suit following the coronavirus disease (COVID-19) outbreak, transports luggage on the tarmac of Wuhan Tianhe International Airport, on a hot summer day in Wuhan, Hubei province, China July 14, 2022. cnsphoto via REUTERS
    China's Wuhan locks down 1m residents amid new Covid cases
  • Covid: CDC flags Bangladesh and 5 other countries as ‘high risk’ for travel
    Covid: CDC flags Bangladesh and 5 other countries as ‘high risk’ for travel

Related News

  • Iran says success of Vienna nuclear talks depends on Washington's flexibility
  • Taiwan is not a part of US but Chinese territory, says Chinese foreign minister
  • US drivers are using less gasoline. Let's keep it that way
  • US says it supports Israel's right to defend itself, urges no more escalation
  • China's July trade surplus with US widens slightly to $41.5b

Features

Safa Shareef’s bridal make-up: Contemporary with a ‘deshi’ touch

Safa Shareef’s bridal make-up: Contemporary with a ‘deshi’ touch

19h | Mode
Infograph: TBS

Why a drastic fuel price hike is dangerous

1d | Panorama
A fuel price hike to fuel agony

A fuel price hike to fuel agony

1d | Panorama
Kamal Uddin Mazumder. Sketch: TBS

Rising foreign debt and balance of payments deficit: Does Bangladesh need to worry?

1d | Thoughts

More Videos from TBS

How Google Maps operates in Bangladesh

How Google Maps operates in Bangladesh

9h | Videos
Is BPC really in loss?

Is BPC really in loss?

10h | Videos
Reasons behind Putin-Erdogan's meeting in Sochi

Reasons behind Putin-Erdogan's meeting in Sochi

15h | Videos
Dr Jamaluddin Ahmed talks about recent fuel price hike

Dr Jamaluddin Ahmed talks about recent fuel price hike

15h | Videos

Most Read

1
Diesel price hiked by Tk34 per litre, Octane by Tk46
Energy

Diesel price hiked by Tk34 per litre, Octane by Tk46

2
Housing projects sprouting up by Dhaka-Mawa expressway
Real Estate

Housing projects sprouting up by Dhaka-Mawa expressway

3
July remittance hits two-year high
Economy

July remittance hits two-year high

4
Infographic: TBS
Banking

Dollar rate will be left to market after two months: Governor

5
Bangladesh to resume talks for Ukrainian wheat import
Economy

Bangladesh to resume talks for Ukrainian wheat import

6
A liquefied natural gas (LNG) tanker is tugged towards a thermal power station in Futtsu, east of Tokyo, Japan November 13, 2017. REUTERS/Issei Kato/File Photo
Energy

Summit proposes long-term LNG supply to Petrobangla

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net